Regulators need patient-centric approach to obesity drug reviews
This article was originally published in Scrip
Executive Summary
Obesity-focused stakeholders are calling on regulators to take a more patient-centric approach when evaluating the benefits and risks of obesity drugs. The George Washington University (GWU) School of Public Health and Health Services has published Obesity drug outcome measures, a report detailing the consensus of findings from a stakeholder dialogue group, convened by the university, outlining a series of new approaches that should be considered by regulators when looking at obesity drugs.